iii期非小细胞肺癌周剂量多西他赛同步适形放疗

iii期非小细胞肺癌周剂量多西他赛同步适形放疗

ID:33984738

大小:2.45 MB

页数:48页

时间:2019-03-03

iii期非小细胞肺癌周剂量多西他赛同步适形放疗_第1页
iii期非小细胞肺癌周剂量多西他赛同步适形放疗_第2页
iii期非小细胞肺癌周剂量多西他赛同步适形放疗_第3页
iii期非小细胞肺癌周剂量多西他赛同步适形放疗_第4页
iii期非小细胞肺癌周剂量多西他赛同步适形放疗_第5页
资源描述:

《iii期非小细胞肺癌周剂量多西他赛同步适形放疗》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库

1、中文摘要⋯⋯·英文摘要·符号说明目录前言⋯⋯资料与方法结果⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯-·29讨论⋯”结论⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯附图⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯4l参考文献⋯⋯⋯⋯⋯·综述⋯⋯⋯⋯致谢⋯⋯⋯⋯⋯⋯⋯⋯”⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯·43攻读硕士期间发表的论文⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯·55原创性声明⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯·surrou

2、nding90%~95%PTv.90%PrVacceptingmini如umabsorbeddose.TheradiationdoseforstageT1~2was60GyandstageT3"~4Was64---66Gy.SupraclavicularlymphaticmetastasisWastreatedwithCobalt-60gammaraysand12MeVelectronrays,thedosesametoprimarytumors.3Othertreatments:Bloodro

3、utineexaminationwasmonitoredeveryweek,hepatorenalfunctionandwaterelectrolytemetabolismmonitoredevery2weeks.Whenleukocyte_<2.0xl09,granulocytecolony-stimulatingfactor(G-CSF)wasused.Thedosageis599/kg/dwithsubcutaneousinjection.Thepatientsexperienced冱gr

4、ademyelosuppressionduringinductionchemotherapyshouldacceptG-CSFprophylacticly,24一-72hoursafterchemotherapy,untilgranuloeytefrommininlll//1leveltonormallevelorleukocyte>i0.Oxl09.Whenthepatientspresentedwithdysfunctionofliver,diammoniumglycyrrhizinatew

5、asinjected,untilaminopherasetonormallevel.Whenpresentedradiationpneumonitisconcomitantwithfever,sputumcultureplusdrugsensitivitytestshouldbecarriedouttoselectreasonableantibiotic,combined州thcoughsuppressantandexpectorant.Whenappearingradiationesophag

6、itis,mucosalanaestheticandglucocorficoidshouldbeused.Whenleukocytedeclining,generaldmgshouldbeused,suchasdiyushengbaitablet,leucogen,batil01.Results1Completedstatus:Allpatientsrceivedthewholetreatmentcourse.ThereWasnoonetoterminateradiotherapy.ThereW

7、asonly10patientsnotfinishing6cyclesweeklydocetaxolbecauseoftransientmyelosuppression,radiationpneumonifisandradiationesophagitis.ThemedianradiotherapytimeofdurationWas43clays(土2days.),andmedianradiotherapydose62Gy(60Gy--。66Gy).2Evaluationoftherapeuti

8、cefficiency:Completeremission13cases(13.1%),partialremission35cases(35.4%),stabledisease24cases(24.2%),progressdisease17cases(17.2%),death7cases(7.1%),losstofollow-up3cases(3.0%).Theresponserate(CR+PR)Was48.5%,diseasecontrolrate(CR+PR+SD)Was72.7%.3Su

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。